Herken, H. Et Al. 2009. The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator-Activated Receptor-gamma 2 Pro12Ala Polymorphism in Patients with Schizophrenia. DNA AND CELL BIOLOGY , vol.28, no.10 , 515-519.

Herken, H., Erdal, M., Aydin, N., Sengul, C., KARADAĞ, R. F., Barlas, O., ... Akin, F.(2009). The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator-Activated Receptor-gamma 2 Pro12Ala Polymorphism in Patients with Schizophrenia. DNA AND CELL BIOLOGY , vol.28, no.10, 515-519.

Herken, Hasan Et Al. "The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator-Activated Receptor-gamma 2 Pro12Ala Polymorphism in Patients with Schizophrenia," DNA AND CELL BIOLOGY , vol.28, no.10, 515-519, 2009

Herken, Hasan Et Al. "The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator-Activated Receptor-gamma 2 Pro12Ala Polymorphism in Patients with Schizophrenia." DNA AND CELL BIOLOGY , vol.28, no.10, pp.515-519, 2009

Herken, H. Et Al. (2009) . "The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator-Activated Receptor-gamma 2 Pro12Ala Polymorphism in Patients with Schizophrenia." DNA AND CELL BIOLOGY , vol.28, no.10, pp.515-519.

@article{article, author={Hasan Herken Et Al. }, title={The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator-Activated Receptor-gamma 2 Pro12Ala Polymorphism in Patients with Schizophrenia}, journal={DNA AND CELL BIOLOGY}, year=2009, pages={515-519} }